Welcome to Paid Research Studies

  • Conditions:   Hypertension in Pregnancy;   Preeclampsia
    Interventions:   Drug: Nifedipine;   Drug: Labetalol
    Sponsors:   Icahn School of Medicine at Mount Sinai;   Mount Sinai Hospital, New York;   Maimonides Medical Center

  • Conditions:   Chronic Hypertension Complicating Pregnancy (Diagnosis);   Preeclampsia
    Interventions:   Drug: Labetalol Hydrocholoride 200 mg orally every 12 hours;   Drug: Nifedipine 60 mg orally daily;   Drug: Atenolol 25 mg daily
    Sponsor:   High Risk Obstetrical Consultants

  • Condition:   Hypertension
    Interventions:   Drug: Anti-hypertensive therapy;   Other: No anti-hypertensive therapy (unless BP is severe)
    Sponsors:   University of Alabama at Birmingham;   Columbia University;   Drexel University College of Medicine;   Rutgers, The State University of New Jersey;   Lehigh Valley Hospital;   Saint Peters University Hospital;   Christiana Care Health Services;   Washington University School of Medicine;   Duke University;   University of Texas Southwestern Medical Center;   The University of Texas Health Science Center, Houston;   Stanford University;   University of Pennsylvania;   The University of Texas Medical Branch, Galveston;   University of Utah;   Intermountain Health Care, Inc.;   University of California, San Francisco;   Johns Hopkins University;   University of Pittsburgh;   Ochsner Health System;   University of North Carolina, Chapel Hill;   National Heart, Lung, and Blood Institute (NHLBI);   WakeMed Health and Hospitals;   San Francisco General Hospital;   McKay-Dee Hospital;   Winthrop University Hospital;   New York Hospital Queens;   Latter Day Saints Hospital;   Lyndon B Johnson General Hospital;   Virtua Medical Group;   Bayview Medical Center;   Duke Regional Hospital;   Utah Valley Regional Medical Center;   Northwestern;   Brown (WIHRI);   Baylor College of Medicine;   Case Western/Metro Health;   Ohio State University;   University of Iowa;   University of California, San Diego;   Indiana University;   Unity Point Health-Meriter Hospital WI;   Weill Medical College of Cornell University;   University of Oklahoma;   Medical University of South Carolina;   Beaumont Hospital;   University of Colorado, Denver;   University of Kansas Medical Center;   Denver Health and Hospital Authority;   Gundersen Health System;   Aurora Health Care;   Oregon Health and Science University;   Medical College of Wisconsin;   Temple University;   New Jersey Medical School;   University of South Alabama;   Vanderbilt University;   University of Arkansas;   Miami Valley Hospital;   Emory University;   St. Luke's University Health Network;   Cleveland Clinic Fairview Hospital;   University of Tennessee Health Science Center;   TriHealth Inc.

  • Condition:   Laparoscopic Surgery
    Interventions:   Drug: Fentanyl;   Drug: Labetalol;   Drug: Esmolol
    Sponsor:   Cedars-Sinai Medical Center